214 related articles for article (PubMed ID: 9528897)
1. The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular disease.
van Besouw NM; Loonen EH; Vaessen LM; Balk AH; Claas FH; Weimar W
Clin Exp Immunol; 1998 Mar; 111(3):548-54. PubMed ID: 9528897
[TBL] [Abstract][Full Text] [Related]
2. The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantation.
van Emmerik NE; Loonen EH; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W
J Heart Lung Transplant; 1997 Feb; 16(2):240-9. PubMed ID: 9059936
[TBL] [Abstract][Full Text] [Related]
3. Differential avidity and cyclosporine sensitivity of committed donor-specific graft-infiltrating cytotoxic T cells and their precursors. Relevance for clinical cardiac graft rejection.
Vaessen LM; Baan CC; Ouwehand AJ; Balk AH; Jutte NH; Mochtar B; Claas FH; Weimar W
Transplantation; 1994 Apr; 57(7):1051-9. PubMed ID: 8165702
[TBL] [Abstract][Full Text] [Related]
4. Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection.
van Emmerik NE; Vaessen LM; Balk AH; Bos E; Claas FH; Weimar W
Transplantation; 1996 Aug; 62(4):529-36. PubMed ID: 8781621
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of circulating cytotoxic T lymphocyte precursors that have a high avidity for donor antigens: correlation with the rejection status of the human cardiac allograft.
van Emmerik NE; Vaessen LM; Knoop CJ; Daane CR; Balk AH; Mochtar B; Claas FH; Weimar W
Transpl Immunol; 1998 Sep; 6(3):153-60. PubMed ID: 9848221
[TBL] [Abstract][Full Text] [Related]
6. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
[TBL] [Abstract][Full Text] [Related]
7. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
8. The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell cultures.
Jutte NH; Groeneveld K; Balk AH; Ouwehand AJ; Loonen EH; Van der Linden M; Strikwerda S; Mochtar B; Claas FH; Weimar W
Clin Exp Immunol; 1994 Oct; 98(1):158-62. PubMed ID: 7923876
[TBL] [Abstract][Full Text] [Related]
9. Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease.
Amir AL; Hagedoorn RS; van Luxemburg-Heijs SA; Marijt EW; Kruisselbrink AB; Frederik Falkenburg JH; Heemskerk MH
Biol Blood Marrow Transplant; 2012 Feb; 18(2):210-9. PubMed ID: 22015995
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular mechanisms of human cardiac myocyte injury after transplantation.
Ansari AA; Sundstrom JB; Kanter K; Mayne A; Villinger F; Gravanis MB; Herskowitz A
J Heart Lung Transplant; 1995; 14(1 Pt 1):102-12. PubMed ID: 7727458
[TBL] [Abstract][Full Text] [Related]
11. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients.
Oei FB; Welters MJ; Knoop CJ; Vaessen LM; Stegmann AP; Weimar W; Bogers AJ
Eur J Cardiothorac Surg; 2000 Oct; 18(4):466-72. PubMed ID: 11024386
[TBL] [Abstract][Full Text] [Related]
12. Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens.
van Kampen CA; Versteeg-van der Voort Maarschalk MF; Roelen DL; ten Berge IJ; Claas FH
Transplantation; 2001 Apr; 71(7):869-74. PubMed ID: 11349718
[TBL] [Abstract][Full Text] [Related]
13. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
14. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
15. Primed CTLs specific for HLA class I may still be present in sensitized patients when anti-HLA antibodies have disappeared: relevance for donor selection.
van Kampen CA; Versteeg-van der Voort Maarschalk MF; Roelen DL; Claas FH
Transplantation; 2002 Apr; 73(8):1286-90. PubMed ID: 11981423
[TBL] [Abstract][Full Text] [Related]
16. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
Roelen DL; van Beelen E; van Bree SP; van Rood JJ; Völker-Dieben HJ; Claas FH
Transplantation; 1995 Apr; 59(7):1039-42. PubMed ID: 7709440
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE
J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487
[TBL] [Abstract][Full Text] [Related]
18. HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.
Wang M; Larsen MV; Nielsen M; Harndahl M; Justesen S; Dziegiel MH; Buus S; Tang ST; Lund O; Claesson MH
PLoS One; 2010 May; 5(5):e10533. PubMed ID: 20479886
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of graft-infiltrating lymphocytes after human heart transplantation. HLA mismatches and the cellular immune response within the transplanted heart.
Ouwehand AJ; Baan CC; Vaessen LM; Jutte NH; Balk AH; Bos E; Claas FH; Weimar W
Hum Immunol; 1994 Apr; 39(4):233-42. PubMed ID: 7915262
[TBL] [Abstract][Full Text] [Related]
20. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
